Société Novus Therapeutics, Inc. Nasdaq
Actions
Recherche biotechnologique et médicale
Métier
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Chief Executive Officer | 51 | 01/05/20 | |
Paul Little
DFI | Director of Finance/CFO | 60 | 15/03/21 |
Steven N. Perrin
PSD | President | 59 | 14/09/20 |
Eliezer Katz
CTO | Chief Tech/Sci/R&D Officer | - | 23/10/23 |
John Herberger
CTO | Chief Tech/Sci/R&D Officer | - | 01/05/22 |
Bryan E. Smith
CMP | Compliance Officer | 45 | 19/04/21 |
David Hovland
LAW | General Counsel | - | 19/04/21 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Keith Katkin
CHM | Chairman | 52 | 01/05/17 |
Walter C. Ogier
BRD | Director/Board Member | 67 | 14/09/20 |
John S. McBride
BRD | Director/Board Member | 72 | 01/05/17 |
Steven N. Perrin
PSD | President | 59 | 14/09/20 |
Chief Executive Officer | 51 | 01/05/20 | |
James Robinson
BRD | Director/Board Member | 54 | 01/10/23 |
June Lee
BRD | Director/Board Member | 58 | 09/12/20 |
Jan Hillson
BRD | Director/Board Member | 71 | 02/07/21 |
Allan Kirk
BRD | Director/Board Member | - | 02/10/23 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 0 | 110 086 | 0 | 0 | 96,45 % |
Action B | 1 | 37 923 614 | 36 577 352 ( 96,45 %) | 0 | |
Action C | 0 | 4 422 | 0 | 0 |
Coordonnées société
Secteur
Varia. 1 janv. | Capi. | |
---|---|---|
+3,91% | 109 Md | |
+10,87% | 105 Md | |
+1,28% | 22,25 Md | |
-13,14% | 22,09 Md | |
-7,05% | 18,68 Md | |
-38,36% | 17,58 Md | |
-10,66% | 16,85 Md | |
+3,75% | 13,76 Md | |
+36,70% | 12,46 Md |